Dennis Podlesak
Managing Partner, Canaan Partners’ Axcelius·Canaan Partners
Princeton, New Jersey, USA
Dennis Podlesak is Managing Partner of Canaan Partners’ Axcelius and Chairman and CEO of Transposon Therapeutics, which he co-founded. He is also Chairman of Syndax Pharmaceuticals and an Advisory Partner to Domain Associates, where he joined as a Partner in 2007. His investment and operating track record includes Tobira Therapeutics, Avanir Pharmaceuticals, RightCare Solutions, Peninsula Pharmaceuticals, Cerexa, Calixa Therapeutics and Corthera.
See the rest of Dennis Podlesak's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.